APCCC 2019 – Advanced Prostate Cancer Consensus Conference
August 29, 2019 - August 31, 2019
Basel, CH
Overview of APCCC
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, molecular characterization, and genetic assays have led to many open questions and areas for which there is sparse or low-level evidence to support clinical decision-making.
The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum to discuss and debate current questions on the clinical management of men with advanced prostate cancer, with a special focus on these unclear situations. Two days of the conference are dedicated to high-level presentations, discussions, and debates to summarize and conceptualize the available literature and evidence.
The conference concludes with voting by an interdisciplinary expert panel on pre-defined consensus questions targeting areas of clinical relevance. Following the conference, a manuscript with these expert recommendations is published in a peer-reviewed journal (Annals of Oncology in 2015; European Urology in 2017).
More information on the conference website.
Next events
EORTC Melanoma Group Autumn Meeting 2024
September 11 - September 12
Barcelona, Spain
CDDF-EORTC Workshop on Innovation and Access in Rare Cancers
September 23 - September 24
Amsterdam, NL (Hybrid Event)
EORTC Quality of Life Group Autumn Meeting 2024
September 26 - September 27
Innsbruck, Austria
EORTC Pathobiology Group Autumn Meeting 2024
October 2
Virtual Event
EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2024
October 9 - October 11
Lausanne, Switzerland